The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNAPS.L Regulatory News (NAPS)

  • There is currently no data for NAPS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Conversion of Loan Notes and Issue of Equity

10 Jun 2021 13:06

RNS Number : 5247B
Napster Group PLC
10 June 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

Napster Group PLC

("NAPS" or the "Company")

Conversion of Loan Notes and Issue of Equity

Napster Group PLC (AIM:NAPS), a leading music company and operator of the MelodyVR and Napster platforms, announces that it has received a notice of exercise from Nice & Green S.A (the "Investor") in respect of the issue of Convertible Loan Notes ("Loan Notes") (as announced on 14 April 2021). This conversion notice follows from the Company having issued a total of £5,840,000 Loan Notes to date under the previously announced investment agreement with the Investor under which Loan Notes with an aggregate value of £8.0 million will be issued.

As a result of this conversion notice £2,300,000 Loan Notes have been converted in to 130,164,120 ordinary shares (the "Conversion Shares") at a conversion price of 1.767p in accordance with the terms of the Loan Notes.

Application will be made for the Conversion Shares to be admitted to trading on AIM with admission expected to take place on or around 16 June 2021. The Conversion Shares will rank pari passu in all respects with all existing ordinary shares in the Company .

Following admission of the Conversion Shares, the Company's enlarged issued share capital will comprise 2,760,945,548 ordinary shares with voting rights. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

For further information please contact; 

Napster Group PLCAnthony Matchett, Group CEO

 

email@napster.group

Arden Partners plc:Nominated Advisor and BrokerCorporate Finance: Ruari McGirr / Antonio Bossi / Akhil ShahCorporate Broking: Simon Johnson 

 

Tel: +44 (0) 20 7614 5900

EquitoryClara Melia/Geoff Callow 

 

napster@equitory.com

www.melodyvr.com

www.napster.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CONURVARAWUNAAR
12
Date   Source Headline
27th Jan 20224:41 pmRNSSecond Price Monitoring Extn
27th Jan 20224:37 pmRNSPrice Monitoring Extension
26th Jan 20222:13 pmRNSUpdate on Disposal & De-listing timetable -Replace
26th Jan 20222:05 pmRNSSecond Price Monitoring Extn
26th Jan 20222:00 pmRNSPrice Monitoring Extension
26th Jan 202211:45 amRNSUpdate on Disposal and De-listing timetable
26th Jan 202211:06 amRNSSecond Price Monitoring Extn
26th Jan 202211:00 amRNSPrice Monitoring Extension
24th Jan 20225:30 pmRNSNapster Group
21st Jan 20222:06 pmRNSSecond Price Monitoring Extn
21st Jan 20222:01 pmRNSPrice Monitoring Extension
19th Jan 20222:06 pmRNSSecond Price Monitoring Extn
19th Jan 20222:00 pmRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSUpdate on Disposal and De-listing timetable
7th Jan 20222:06 pmRNSSecond Price Monitoring Extn
7th Jan 20222:01 pmRNSPrice Monitoring Extension
4th Jan 20224:40 pmRNSSecond Price Monitoring Extn
4th Jan 20224:35 pmRNSPrice Monitoring Extension
4th Jan 20222:06 pmRNSSecond Price Monitoring Extn
4th Jan 20222:01 pmRNSPrice Monitoring Extension
30th Dec 20214:41 pmRNSSecond Price Monitoring Extn
30th Dec 20214:36 pmRNSPrice Monitoring Extension
30th Dec 20219:06 amRNSSecond Price Monitoring Extn
30th Dec 20219:00 amRNSPrice Monitoring Extension
21st Dec 20217:00 amRNSResult of General Meeting
10th Dec 202112:45 pmRNSDirector/PDMR Shareholding
3rd Dec 20214:41 pmRNSSecond Price Monitoring Extn
3rd Dec 20214:35 pmRNSPrice Monitoring Extension
3rd Dec 20214:15 pmRNSUndertakings update and posting of Circular
3rd Dec 202111:06 amRNSSecond Price Monitoring Extn
3rd Dec 202111:00 amRNSPrice Monitoring Extension
3rd Dec 20217:01 amRNSConversion of Loan Notes and Issue of Equity
3rd Dec 20217:00 amRNSEBT Subscription, Director/PDMR Shareholding
2nd Dec 20214:41 pmRNSSecond Price Monitoring Extn
2nd Dec 20214:35 pmRNSPrice Monitoring Extension
2nd Dec 20212:05 pmRNSSecond Price Monitoring Extn
2nd Dec 20212:00 pmRNSPrice Monitoring Extension
2nd Dec 20211:14 pmRNSProposed Disposal & Proposed Delisting from AIM
30th Sep 20217:00 amRNSHalf-year Report
10th Sep 202111:00 amRNSPrice Monitoring Extension
9th Sep 20214:41 pmRNSSecond Price Monitoring Extn
9th Sep 20214:36 pmRNSPrice Monitoring Extension
16th Aug 20218:39 amRNSHolding(s) in Company
12th Aug 20213:40 pmRNSResult of AGM
3rd Aug 20217:00 amRNSConversion of Loan Notes and Share Subscription
20th Jul 20218:15 amRNSNotice of AGM
19th Jul 202111:05 amRNSSecond Price Monitoring Extn
19th Jul 202111:00 amRNSPrice Monitoring Extension
19th Jul 20217:01 amRNSBoard Changes
19th Jul 20217:00 amRNSChange of Adviser
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.